South Korea
· Delayed Price · Currency is KRW MedPacto Statistics
Total Valuation
MedPacto has a market cap or net worth of KRW 148.59 billion. The enterprise value is 98.23 billion.
| Market Cap | 148.59B |
| Enterprise Value | 98.23B |
Important Dates
The next estimated earnings date is Wednesday, March 19, 2025.
| Earnings Date | Mar 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
MedPacto has 33.58 million shares outstanding. The number of shares has decreased by -8.33% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 33.58M |
| Shares Change (YoY) | -8.33% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 13.43% |
| Owned by Institutions (%) | 6.31% |
| Float | 24.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.64 |
| P/TBV Ratio | 2.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.21 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.63 |
Financial Position
The company has a current ratio of 27.32, with a Debt / Equity ratio of 0.03.
| Current Ratio | 27.32 |
| Quick Ratio | 26.69 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.09 |
| Interest Coverage | -264.78 |
Financial Efficiency
Return on equity (ROE) is -68.92% and return on invested capital (ROIC) is -44.29%.
| Return on Equity (ROE) | -68.92% |
| Return on Assets (ROA) | -36.94% |
| Return on Capital (ROIC) | -44.29% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -416.19M |
| Employee Count | 56 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.53% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -33.53% |
| 50-Day Moving Average | 5,112.40 |
| 200-Day Moving Average | 8,153.15 |
| Relative Strength Index (RSI) | 41.30 |
| Average Volume (20 Days) | 342,420 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -24.65B |
| Pretax Income | -23.31B |
| Net Income | -23.31B |
| EBITDA | -23.05B |
| EBIT | -24.65B |
| Earnings Per Share (EPS) | -761.83 |
Balance Sheet
The company has 58.49 billion in cash and 1.95 billion in debt, giving a net cash position of 56.54 billion or 1,683.75 per share.
| Cash & Cash Equivalents | 58.49B |
| Total Debt | 1.95B |
| Net Cash | 56.54B |
| Net Cash Per Share | 1,683.75 |
| Equity (Book Value) | 62.40B |
| Book Value Per Share | 1,674.13 |
| Working Capital | 59.98B |
Cash Flow
In the last 12 months, operating cash flow was -21.05 billion and capital expenditures -153.02 million, giving a free cash flow of -21.21 billion.
| Operating Cash Flow | -21.05B |
| Capital Expenditures | -153.02M |
| Free Cash Flow | -21.21B |
| FCF Per Share | -631.48 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MedPacto does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.33% |
| Shareholder Yield | 8.33% |
| Earnings Yield | -17.22% |
| FCF Yield | -14.27% |
Stock Splits
The last stock split was on May 13, 2020. It was a forward split with a ratio of 2.
| Last Split Date | May 13, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |